InSphero Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 60
Employees
  • Latest Deal Type
  • Debt
  • Investors
  • 6

InSphero General Information

Description

Provider of 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology designed to deliver biologically relevant insights for in vitro testing. The company's technology helps identify drugs and toxic liabilities with predictive power at early development stages, enabling pharmaceutical and biotechnological industries to make better preclinical decisions, reduce development costs and shorten time to reduce animal use in testing.

Contact Information

Website
www.insphero.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • Wagistrasse 27A
  • 8952 Schlieren
  • Switzerland
+41 044 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InSphero Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Debt - General 000.00 Completed Generating Revenue
9. Later Stage VC 13-Jun-2018 0000 000.00 Completed Generating Revenue
8. Grant 21-Oct-2015 00000 000.00 Completed Generating Revenue
7. Secondary Transaction - Private 12-Oct-2015 000.00 Completed Generating Revenue
6. Later Stage VC (Series C) 08-Jul-2015 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series B) 13-Jun-2013 00.00 00.000 Completed Startup
4. Grant 27-Mar-2012 00.000 00.000 Completed Startup
3. Later Stage VC (Series A) 02-Aug-2010 00.000 00.000 Completed Startup
2. Later Stage VC 01-Jan-2009 $139K Completed Startup
1. Accelerator/Incubator $139K $139K Completed Startup
To view InSphero’s complete valuation and funding history, request access »

InSphero Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology designed to deliver biological
Biotechnology
Schlieren, Switzerland
60 As of 2021
000.00
0000 000.00

00000000

d exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in rep
0000000000000
Orlando, FL
00 As of 0000
000000000 -

0000 000

et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000000000000
Ecublens, Switzerland
0 As of 0000
00.000
000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InSphero Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hesperos Accelerator/Incubator Backed Orlando, FL 00 000000000 -
0000 0000000000 Venture Capital-Backed Ecublens, Switzerland 0 00.000 000000 0 00.000
000000 0000000000 Venture Capital-Backed Vancouver, Canada 00 000.00 00000000000 000.00
00 000 00000000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 0000000000 0 000.00
0000000 000000000 Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
You’re viewing 5 of 20 competitors. Get the full list »

InSphero Patents

  • 51

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 7

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

InSphero Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210245945-A1 Transport device with an inner container Pending 06-Sep-2018 000000000
CA-3108037-A1 Transport device with an inner container Granted 06-Sep-2018 000000000
CA-3064348-A1 Microtissue compartment device Granted 07-Jul-2017 000000000
CA-3064348-C Microtissue compartment device Active 07-Jul-2017 000000000
GB-201710955-D0 Microtissue compartment device Ceased 07-Jul-2017 C12M21/08
To view InSphero’s complete patent history, request access »

InSphero Executive Team (15)

Name Title Board Seat Contact Info
Jan Lichtenberg Ph.D Co-Founder, Chief Executive Officer & Board Member
Armin Wolf Ph.D Chief Scientific Officer
Frank Junker Chief Business Officer
Wolfgang Moritz Ph.D Co-Founder & Head of External Development Collaborations & IP
Marion Bavand Head, Quality Assurance
You’re viewing 5 of 15 executive team members. Get the full list »

InSphero Board Members (11)

Name Representing Role Since
Anna Evdokimova Self Board Member 000 0000
Beat Schillig Self Board Member 000 0000
Jan Lichtenberg Ph.D InSphero Co-Founder, Chief Executive Officer & Board Member 000 0000
Jürg Gysi Ph.D InSphero Chairman of the Board, Switzerland 000 0000
Thomas Pfisterer InSphero Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

InSphero Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InSphero Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Occident Group Venture Capital Minority 000 0000 000000 0
VentureLab Accelerator/Incubator Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Zürcher Kantonalbank Corporation Minority 000 0000 000000 0
Startup Invest Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial